Round 2046
Round 20 of 20 in simulation 6 of South Korea, greedy, 20 years: 3 actions, Chronic disease advance, and the index +0.139 to 17.59.
Model 0.1.0 · graph 0.2.0 · parameters 0.1.0
State in and state out
The simulation as it came into 2046 (the end of 2045) and as it left it.
- Capability index
- 17.59 (+0.138)
- In: 17.45
- Rank by index
- 2
- In: 2
- Domains at Tier 1
- 7
- In: 7
- Credits carried
- 9
- In: 4
| Domain | In | Out | Change | Tier |
|---|---|---|---|---|
| Critical Technology | 17.18 | 17.50 | +0.325 | 2 |
| Strategic Infrastructure | 16.58 | 16.65 | +0.067 | 1 |
| National Security | 13.51 | 13.52 | +0.013 | 3 |
| Human Capital | 19.30 | 19.39 | +0.080 | 1 |
| Information & Influence | 17.88 | 17.97 | +0.084 | 1 |
| Governance & Integrity | 18.35 | 18.41 | +0.066 | 1 |
| Financial Strength | 16.93 | 17.47 | +0.533 | 1 |
| Production & Innovation | 18.50 | 18.54 | +0.043 | 1 |
| Trade & Investment | 18.84 | 18.87 | +0.039 | 1 |
Decision, shocks and propagation
What happened in 2046: the credits, the greedy method's decision and its actions, any shocks and upside events, the tier changes, and the groups that moved most, split into what was invested, lost to decay, struck by events and carried through the dependency graph.
Credits. Income 995, plus 4 carried in. Maintenance 880. Spent 110 on actions (buy 110). 9 carried over.
- BuyAdvanced Materials & Manufacturing50 credits for 2.05 levelshighest_marginal_returnahead of Sovereign Capital & External Financial Power by 1 per cent
- BuySovereign Capital & External Financial Power50 credits for 2.06 levelshighest_marginal_returnahead of Biotechnology & Health Technologies by 1 per cent
- BuyBiotechnology & Health Technologies10 credits for 0.46 levelshighest_marginal_returnahead of Energy Technologies by 3 per cent
- Upside event: Chronic disease advance S19. +15.8 points across the groups it bears on, after exposure and readiness, spread over its duration.
| Moved most | Change | Invested | Decay | Events | Graph |
|---|---|---|---|---|---|
| Sovereign Capital & External Financial Power | +2.13 | +2.06 | 0.00 | +0.06 | +0.01 |
| Advanced Materials & Manufacturing | +2.11 | +2.05 | 0.00 | +0.06 | −0.01 |
| Monetary & Currency Capability | +0.74 | +0.68 | 0.00 | +0.06 | +0.01 |
| Biotechnology & Health Technologies | +0.57 | +0.46 | 0.00 | +0.12 | −0.01 |
| Diaspora & Global Communities | +0.33 | +0.30 | 0.00 | +0.03 | 0.00 |
| Government Effectiveness & Public Administration | +0.18 | 0.00 | 0.00 | +0.12 | +0.06 |